Cuca Roberto's Insider Trades & SAST Disclosures
Cuca Roberto's most recent trade in TELA Bio Inc was a trade of 83,800 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Cuca Roberto.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TELA Bio Inc | Roberto Cuca | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 83,800 | 83,800 | - | - | Stock Option (Right to Buy) | |
| TELA Bio Inc | Roberto Cuca | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 57,000 | 213,467 (1%) | 0% | 0 | Common Stock | |
| TELA Bio Inc | Roberto Cuca | COO and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.72 per share. | 21 Feb 2025 | 5,234 | 208,233 (1%) | 0% | 2.7 | 14,236 | Common Stock |
| TELA Bio Inc | Roberto Cuca | COO and CFO | Purchase of securities on an exchange or from another person at price $ 2.25 per share. | 24 Oct 2024 | 64,444 | 155,388 (1%) | 0% | 2.3 | 144,999 | Common Stock |
| TELA Bio Inc | Cuca Roberto | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 42,700 | 42,700 | - | - | Stock Option (Right to Buy) | |
| TELA Bio Inc | Roberto Cuca | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 29,200 | 92,650 (0%) | 0% | 0 | Common Stock | |
| TELA Bio Inc | Cuca Roberto | COO and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.07 per share. | 23 Feb 2024 | 2,785 | 89,865 (0%) | 0% | 7.1 | 19,690 | Common Stock |
| TELA Bio Inc | Roberto Cuca | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 27,700 | 27,700 | - | - | Stock Option (Right to Buy) | |
| TELA Bio Inc | Roberto Cuca | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 17,700 | 52,592 (0%) | 0% | 0 | Common Stock | |
| TELA Bio Inc | Roberto Cuca | COO and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.50 per share. | 23 Feb 2023 | 1,300 | 51,292 (0%) | 0% | 10.5 | 13,650 | Common Stock |
| TELA Bio Inc | Roberto Cuca | COO and CFO | Purchase of securities on an exchange or from another person at price $ 5.50 per share. | 07 Jun 2022 | 15,000 | 34,892 (0%) | 0% | 5.5 | 82,500 | Common Stock |
| TELA Bio Inc | Roberto Cuca | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 26,600 | 26,600 | - | - | Stock Option (Right to Buy) | |
| TELA Bio Inc | Roberto Cuca | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 15,500 | 19,892 (0%) | 0% | 0 | Common Stock | |
| TELA Bio Inc | Roberto Cuca | COO and CFO | Purchase of securities on an exchange or from another person at price $ 12.67 per share. | 02 Dec 2021 | 1,351 | 4,392 (0%) | 0% | 12.7 | 17,117 | Common Stock |
| TELA Bio Inc | Roberto Cuca | COO and CFO | Purchase of securities on an exchange or from another person at price $ 12.64 per share. | 29 Nov 2021 | 1,780 | 3,041 (0%) | 0% | 12.6 | 22,499 | Common Stock |
| TELA Bio Inc | Roberto Cuca | COO and CFO | Purchase of securities on an exchange or from another person at price $ 12.43 per share. | 29 Nov 2021 | 838 | 1,261 (0%) | 0% | 12.4 | 10,416 | Common Stock |
| TELA Bio Inc | Roberto Cuca | COO and CFO | Purchase of securities on an exchange or from another person at price $ 12.60 per share. | 29 Nov 2021 | 423 | 423 (0%) | 0% | 12.6 | 5,330 | Common Stock |
| TELA Bio Inc | Roberto Cuca | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2021 | 144,000 | 144,000 | - | - | Stock Option (Right to Buy) | |
| Orasure Technologies Inc. | Roberto Cuca | CFO | Grant, award, or other acquisition of securities at price $ 9.85 per share. | 07 May 2021 | 10,740 | 118,219 (0%) | 0% | 9.9 | 105,789 | Common Stock |
| Orasure Technologies Inc. | Roberto Cuca | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.85 per share. | 07 May 2021 | 3,404 | 114,815 (0%) | 0% | 9.8 | 33,529 | Common Stock |
| Orasure Technologies Inc. | Roberto Cuca | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.85 per share. | 07 May 2021 | 1,359 | 107,479 (0%) | 0% | 9.8 | 13,386 | Common Stock |
| Orasure Technologies Inc. | Roberto Cuca | CFO | Grant, award, or other acquisition of securities at price $ 15.55 per share. | 01 Feb 2021 | 24,706 | 108,838 (0%) | 0% | 15.6 | 384,299 | Common Stock |
| Orasure Technologies Inc. | Roberto Cuca | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. | 01 Feb 2021 | 4,525 | 84,132 (0%) | 0% | 15.6 | 70,386 | Common Stock |
| Orasure Technologies Inc. | Roberto Cuca | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. | 01 Feb 2021 | 2,696 | 88,657 (0%) | 0% | 15.6 | 41,936 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges